Benjamin Weigel
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
- Pharmacology top 10%
- Microbial Natural Products and Biosynthesis
Papers in
-
- Microbial Natural Products and Biosynthesis 5
-
- Plant biochemistry and biosynthesis 3
- Co-authors
- Thomas D. Ingolia (2 shared papers)James R. Miller (1 shared paper)S Kovacevic (1 shared paper)Martin D. Tobin (1 shared paper)Ludger A. Wessjohann (3 shared papers)S. W. QUEENER (1 shared paper)Paul L. Skatrud (1 shared paper)Charles A. Frolik (1 shared paper)
- Journals
- Journal of Bacteriology (2 papers)The Plant Cell (1 paper)ChemCatChem (1 paper)Current Opinion in Chemical Biology (1 paper)ChemBioChem (1 paper)
- Partner nations
- GermanyUnited States
In The Last Decade
Benjamin Weigel
8 papers receiving 390 citations
Peers
Comparison fields: 5 of 59
- Molecular Medicine 46
- Pharmacology 139
- Microbiology 5
- Molecular Biology 242
- Biotechnology 28
Countries citing papers authored by Benjamin Weigel
This map shows the geographic impact of Benjamin Weigel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Weigel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Weigel more than expected).
Fields of papers citing papers by Benjamin Weigel
This network shows the impact of papers produced by Benjamin Weigel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Weigel. The network helps show where Benjamin Weigel may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Weigel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 107 | |
| 2 | 1989 | 91 | |
| 3 | 2014 | 85 | |
| 4 | 2013 | 54 | |
| 5 | 1987 | 33 | |
| 6 | 1990 | 24 | |
| 7 | 2022 | 11 | |
| 8 | 2022 | 5 |
About Benjamin Weigel
Benjamin Weigel is a scholar working on Pharmacology, Molecular Biology, Hematology, Genetics and Cancer Research, having authored 8 papers that have together received 410 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (5 papers), Plant biochemistry and biosynthesis (3 papers), Bacterial Genetics and Biotechnology (2 papers), Protease and Inhibitor Mechanisms (2 papers), Postharvest Quality and Shelf Life Management (1 paper), Antimicrobial Resistance in Staphylococcus (1 paper), Plant Surface Properties and Treatments (1 paper) and Plant Pathogens and Fungal Diseases (1 paper). The work is most often cited by research in Molecular Medicine (46 citations), Pharmacology (139 citations), Microbiology (5 citations), Molecular Biology (242 citations) and Biotechnology (28 citations). Benjamin Weigel has collaborated with scholars based in Germany and United States. Frequent co-authors include Thomas D. Ingolia, James R. Miller, S Kovacevic, Martin D. Tobin, Ludger A. Wessjohann, S. W. QUEENER, Paul L. Skatrud, Charles A. Frolik, Stanley G. Burgett and Martin Dippe. Their work appears in journals such as Journal of Bacteriology, The Plant Cell, ChemCatChem, Current Opinion in Chemical Biology and ChemBioChem.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.